Patent details

EP3345618 Title: AGENT FOR ENHANCING IMMUNITY TO CANCER BY USING ALLERGIN-1 ANTAGONIST

Basic Information

Publication number:
EP3345618
PCT Application Number:
JP2016075887
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP168420263
PCT Publication Number:
WO2017038997
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AGENT FOR ENHANCING IMMUNITY TO CANCER BY USING ALLERGIN-1 ANTAGONIST
French Title of Invention:
AGENT DESTINÉ À AMÉLIORER L'IMMUNITÉ CONTRE LE CANCER EMPLOYANT UN ANTAGONISTE D'ALLERGINE-1
German Title of Invention:
MITTEL ZUR VERBESSERUNG DER IMMUNITÄT GEGEN KREBS DURCH VERWENDUNG EINES ALLERGIN-1-ANTAGONISTEN
SPC Number:

Dates

Filing date:
02/09/2016
Grant date:
05/01/2022
EP Publication Date:
11/07/2018
PCT Publication Date:
09/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/01/2022
EP B1 Publication Date:
05/01/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
02/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/12/2021
 
 

Name:
ONO Pharmaceutical Co., Ltd.
Address:
1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526, Japan (JP)

Agent

Name:
MARKS & CLERK LLP
From:
05/01/2022
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
ARIMA, Hiroshi
Address:
Japan (JP)

2

Name:
SHIBAYAMA, Shiro
Address:
Japan (JP)

3

Name:
SIMBO, Takuya
Address:
Japan (JP)

Priority

1

Priority Number:
2015173659
Priority Date:
03/09/2015
Priority Country:
Japan (JP)

2

Priority Number:
2016138374
Priority Date:
13/07/2016
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 39/395; A61K 38/00; A61K 45/00; A61K 45/06; A61P 35/00; A61P 35/02; A61P 37/04; A61P 43/00; A01K 67/027; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202201
Publication date:
05/01/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
29/08/2024
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56
05/01/2022 Power Of Attorney 1
05/01/2022 Outgoing Correspondence 1